HALLIE TAYLOR: Open Payments
NPI 1114540739 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,422 in 100 payments from 14 companies in 2025. Trend: 2023 $563 · 2024 $1,675 · 2025 $2,422
Food & beverage: $2,322Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $685 |
| Regeneron Healthcare Solutions, Inc. | 16 | $381 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $271 |
| CSL Behring | 7 | $198 |
| Amgen Inc. | 9 | $182 |
| GlaxoSmithKline, LLC. | 9 | $175 |
| GENZYME CORPORATION | 5 | $159 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Grifols USA, LLC | 3 | $70 |
| Organon LLC | 3 | $43 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, FASENRA, Hizentra, AIRSUPRA, TRELEGY ELLIPTA, NUCALA.
Industry payments across AL — which companies pay providers there.
